Please assess the completion status of the following clinical trial:

Trial Title: Tamsulosin to Prevent Postoperative Urinary Retention in Laparoscopic Inguinal Hernia Repair

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. All patients undergoing elective laparoscopic inguinal hernia repair, unilateral or bilateral.~2. ≥18 years of age.~3. Patients must leave the operating room without at indwelling urinary catheter.~Exclusion Criteria:~1. History of neurogenic bladder requiring routine intermittent catheterization~2. Emergent laparoscopic hernia repair.~3. Elective laparoscopic hernia repair in conjuncture with an additional operation (e.g. nephrectomy, pelvic surgery) that requires the patient to have a planned, indwelling urinary catheter in the postoperative period.~4. Pregnant women.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Patients undergoing laparoscopic inguinal hernia repair will randomized to one dose of placebo in the preoperative holding area 2 hours before surgery.
- Interventional (Type: EXPERIMENTAL): Patients undergoing laparoscopic inguinal hernia repair will be randomized to one dose of 0.4 mg tamsulosin in the preoperative holding area 2 hours before surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).